Antibody decay, T cell immunity and breakthrough infections following two SARS-CoV-2 vaccine doses in inflammatory bowel disease patients treated with infliximab and vedolizumab.
Saved in:
| Title: | Antibody decay, T cell immunity and breakthrough infections following two SARS-CoV-2 vaccine doses in inflammatory bowel disease patients treated with infliximab and vedolizumab. |
|---|---|
| Authors: | Lin S; Department of Gastroenterology, Royal Devon and Exeter NHS Foundation Trust, Exeter, UK.; Exeter Inflammatory Bowel Disease and Pharmacogenetics Research Group, University of Exeter, Exeter, UK., Kennedy NA; Department of Gastroenterology, Royal Devon and Exeter NHS Foundation Trust, Exeter, UK.; Exeter Inflammatory Bowel Disease and Pharmacogenetics Research Group, University of Exeter, Exeter, UK., Saifuddin A; Department of Gastroenterology, St Marks Hospital and Academic Institute, London, UK.; Department of Metabolism, Digestion and Reproduction, Imperial College London, London, UK., Sandoval DM; Department of Infectious Disease, Imperial College London, London, UK., Reynolds CJ; Department of Infectious Disease, Imperial College London, London, UK., Seoane RC; Department of Immunology and Inflammation, Imperial College London, London, United Kingdom., Kottoor SH; Department of Metabolism, Digestion and Reproduction, Imperial College London, London, UK., Pieper FP; Department of Infectious Disease, Imperial College London, London, UK., Lin KM; Department of Infectious Disease, Imperial College London, London, UK., Butler DK; Department of Infectious Disease, Imperial College London, London, UK., Chanchlani N; Department of Gastroenterology, Royal Devon and Exeter NHS Foundation Trust, Exeter, UK.; Exeter Inflammatory Bowel Disease and Pharmacogenetics Research Group, University of Exeter, Exeter, UK., Nice R; Exeter Inflammatory Bowel Disease and Pharmacogenetics Research Group, University of Exeter, Exeter, UK.; Department of Biochemistry, Exeter Clinical Laboratory International, Royal Devon and Exeter NHS Foundation Trust, Exeter, UK., Chee D; Department of Gastroenterology, Royal Devon and Exeter NHS Foundation Trust, Exeter, UK.; Exeter Inflammatory Bowel Disease and Pharmacogenetics Research Group, University of Exeter, Exeter, UK., Bewshea C; Exeter Inflammatory Bowel Disease and Pharmacogenetics Research Group, University of Exeter, Exeter, UK., Janjua M; Department of Gastroenterology, Royal Devon and Exeter NHS Foundation Trust, Exeter, UK.; Exeter Inflammatory Bowel Disease and Pharmacogenetics Research Group, University of Exeter, Exeter, UK., McDonald TJ; Department of Biochemistry, Exeter Clinical Laboratory International, Royal Devon and Exeter NHS Foundation Trust, Exeter, UK., Sebastian S; IBD Unit, Department of Gastroenterology, Hull University Teaching Hospitals NHS Trust, Hull, UK.; Hull York Medical School, University of Hull, Hull, UK., Alexander JL; Department of Metabolism, Digestion and Reproduction, Imperial College London, London, UK.; Department of Gastroenterology, Imperial College Healthcare NHS Trust, London, UK., Constable L; Department of Metabolism, Digestion and Reproduction, Imperial College London, London, UK., Lee JC; Department of Gastroenterology, Royal Free London NHS Foundation Trust, London, UK.; Genetic Mechanisms of Disease Laboratory, The Francis Crick Institute, London, UK.; Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, University of Cambridge, Cambridge, UK., Murray CD; Department of Gastroenterology, Royal Free London NHS Foundation Trust, London, UK., Hart AL; Department of Gastroenterology, St Marks Hospital and Academic Institute, London, UK., Irving PM; Department of Gastroenterology, Guy's and St Thomas' NHS Foundation Trust, London, UK.; School of Immunology & Microbial Sciences, King's College London, London, UK., Jones GR; Department of Gastroenterology, Western General Hospital, NHS Lothian, Edinburgh, UK.; Centre for Inflammation Research, The Queen's Medical Research Institute, The University of Edinburgh, Edinburgh, UK., Kok KB; Department of Gastroenterology, Royal London Hospital, Barts Health NHS Trust, London, UK.; Centre for Immunobiology, Blizard Institute, Barts and the London School of Medicine, Queen Mary University of London, London, UK., Lamb CA; Department of Gastroenterology, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.; Translational & Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK., Lees CW; Department of Gastroenterology, Western General Hospital, NHS Lothian, Edinburgh, UK.; Institute of Genetic and Molecular Medicine, University of Edinburgh, Edinburgh, UK., Altmann DM; Department of Immunology and Inflammation, Imperial College London, London, United Kingdom., Boyton RJ; Department of Infectious Disease, Imperial College London, London, UK.; Lung Division, Royal Brompton Hospital and Harefield Hospitals, London, UK., Goodhand JR; Department of Gastroenterology, Royal Devon and Exeter NHS Foundation Trust, Exeter, UK.; Exeter Inflammatory Bowel Disease and Pharmacogenetics Research Group, University of Exeter, Exeter, UK., Powell N; Department of Metabolism, Digestion and Reproduction, Imperial College London, London, UK.; Department of Gastroenterology, Imperial College Healthcare NHS Trust, London, UK., Ahmad T; Department of Gastroenterology, Royal Devon and Exeter NHS Foundation Trust, Exeter, UK. tariq.ahmad1@nhs.net.; Exeter Inflammatory Bowel Disease and Pharmacogenetics Research Group, University of Exeter, Exeter, UK. tariq.ahmad1@nhs.net. |
| Corporate Authors: | CLARITY IBD study |
| Source: | Nature communications [Nat Commun] 2022 Mar 16; Vol. 13 (1), pp. 1379. Date of Electronic Publication: 2022 Mar 16. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 35296643 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Antibody decay, T cell immunity and breakthrough infections following two SARS-CoV-2 vaccine doses in inflammatory bowel disease patients treated with infliximab and vedolizumab. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Lin+S%22">Lin S</searchLink>; Department of Gastroenterology, Royal Devon and Exeter NHS Foundation Trust, Exeter, UK.; Exeter Inflammatory Bowel Disease and Pharmacogenetics Research Group, University of Exeter, Exeter, UK.<br /><searchLink fieldCode="AU" term="%22Kennedy+NA%22">Kennedy NA</searchLink>; Department of Gastroenterology, Royal Devon and Exeter NHS Foundation Trust, Exeter, UK.; Exeter Inflammatory Bowel Disease and Pharmacogenetics Research Group, University of Exeter, Exeter, UK.<br /><searchLink fieldCode="AU" term="%22Saifuddin+A%22">Saifuddin A</searchLink>; Department of Gastroenterology, St Marks Hospital and Academic Institute, London, UK.; Department of Metabolism, Digestion and Reproduction, Imperial College London, London, UK.<br /><searchLink fieldCode="AU" term="%22Sandoval+DM%22">Sandoval DM</searchLink>; Department of Infectious Disease, Imperial College London, London, UK.<br /><searchLink fieldCode="AU" term="%22Reynolds+CJ%22">Reynolds CJ</searchLink>; Department of Infectious Disease, Imperial College London, London, UK.<br /><searchLink fieldCode="AU" term="%22Seoane+RC%22">Seoane RC</searchLink>; Department of Immunology and Inflammation, Imperial College London, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Kottoor+SH%22">Kottoor SH</searchLink>; Department of Metabolism, Digestion and Reproduction, Imperial College London, London, UK.<br /><searchLink fieldCode="AU" term="%22Pieper+FP%22">Pieper FP</searchLink>; Department of Infectious Disease, Imperial College London, London, UK.<br /><searchLink fieldCode="AU" term="%22Lin+KM%22">Lin KM</searchLink>; Department of Infectious Disease, Imperial College London, London, UK.<br /><searchLink fieldCode="AU" term="%22Butler+DK%22">Butler DK</searchLink>; Department of Infectious Disease, Imperial College London, London, UK.<br /><searchLink fieldCode="AU" term="%22Chanchlani+N%22">Chanchlani N</searchLink>; Department of Gastroenterology, Royal Devon and Exeter NHS Foundation Trust, Exeter, UK.; Exeter Inflammatory Bowel Disease and Pharmacogenetics Research Group, University of Exeter, Exeter, UK.<br /><searchLink fieldCode="AU" term="%22Nice+R%22">Nice R</searchLink>; Exeter Inflammatory Bowel Disease and Pharmacogenetics Research Group, University of Exeter, Exeter, UK.; Department of Biochemistry, Exeter Clinical Laboratory International, Royal Devon and Exeter NHS Foundation Trust, Exeter, UK.<br /><searchLink fieldCode="AU" term="%22Chee+D%22">Chee D</searchLink>; Department of Gastroenterology, Royal Devon and Exeter NHS Foundation Trust, Exeter, UK.; Exeter Inflammatory Bowel Disease and Pharmacogenetics Research Group, University of Exeter, Exeter, UK.<br /><searchLink fieldCode="AU" term="%22Bewshea+C%22">Bewshea C</searchLink>; Exeter Inflammatory Bowel Disease and Pharmacogenetics Research Group, University of Exeter, Exeter, UK.<br /><searchLink fieldCode="AU" term="%22Janjua+M%22">Janjua M</searchLink>; Department of Gastroenterology, Royal Devon and Exeter NHS Foundation Trust, Exeter, UK.; Exeter Inflammatory Bowel Disease and Pharmacogenetics Research Group, University of Exeter, Exeter, UK.<br /><searchLink fieldCode="AU" term="%22McDonald+TJ%22">McDonald TJ</searchLink>; Department of Biochemistry, Exeter Clinical Laboratory International, Royal Devon and Exeter NHS Foundation Trust, Exeter, UK.<br /><searchLink fieldCode="AU" term="%22Sebastian+S%22">Sebastian S</searchLink>; IBD Unit, Department of Gastroenterology, Hull University Teaching Hospitals NHS Trust, Hull, UK.; Hull York Medical School, University of Hull, Hull, UK.<br /><searchLink fieldCode="AU" term="%22Alexander+JL%22">Alexander JL</searchLink>; Department of Metabolism, Digestion and Reproduction, Imperial College London, London, UK.; Department of Gastroenterology, Imperial College Healthcare NHS Trust, London, UK.<br /><searchLink fieldCode="AU" term="%22Constable+L%22">Constable L</searchLink>; Department of Metabolism, Digestion and Reproduction, Imperial College London, London, UK.<br /><searchLink fieldCode="AU" term="%22Lee+JC%22">Lee JC</searchLink>; Department of Gastroenterology, Royal Free London NHS Foundation Trust, London, UK.; Genetic Mechanisms of Disease Laboratory, The Francis Crick Institute, London, UK.; Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, University of Cambridge, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Murray+CD%22">Murray CD</searchLink>; Department of Gastroenterology, Royal Free London NHS Foundation Trust, London, UK.<br /><searchLink fieldCode="AU" term="%22Hart+AL%22">Hart AL</searchLink>; Department of Gastroenterology, St Marks Hospital and Academic Institute, London, UK.<br /><searchLink fieldCode="AU" term="%22Irving+PM%22">Irving PM</searchLink>; Department of Gastroenterology, Guy's and St Thomas' NHS Foundation Trust, London, UK.; School of Immunology & Microbial Sciences, King's College London, London, UK.<br /><searchLink fieldCode="AU" term="%22Jones+GR%22">Jones GR</searchLink>; Department of Gastroenterology, Western General Hospital, NHS Lothian, Edinburgh, UK.; Centre for Inflammation Research, The Queen's Medical Research Institute, The University of Edinburgh, Edinburgh, UK.<br /><searchLink fieldCode="AU" term="%22Kok+KB%22">Kok KB</searchLink>; Department of Gastroenterology, Royal London Hospital, Barts Health NHS Trust, London, UK.; Centre for Immunobiology, Blizard Institute, Barts and the London School of Medicine, Queen Mary University of London, London, UK.<br /><searchLink fieldCode="AU" term="%22Lamb+CA%22">Lamb CA</searchLink>; Department of Gastroenterology, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.; Translational & Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK.<br /><searchLink fieldCode="AU" term="%22Lees+CW%22">Lees CW</searchLink>; Department of Gastroenterology, Western General Hospital, NHS Lothian, Edinburgh, UK.; Institute of Genetic and Molecular Medicine, University of Edinburgh, Edinburgh, UK.<br /><searchLink fieldCode="AU" term="%22Altmann+DM%22">Altmann DM</searchLink>; Department of Immunology and Inflammation, Imperial College London, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Boyton+RJ%22">Boyton RJ</searchLink>; Department of Infectious Disease, Imperial College London, London, UK.; Lung Division, Royal Brompton Hospital and Harefield Hospitals, London, UK.<br /><searchLink fieldCode="AU" term="%22Goodhand+JR%22">Goodhand JR</searchLink>; Department of Gastroenterology, Royal Devon and Exeter NHS Foundation Trust, Exeter, UK.; Exeter Inflammatory Bowel Disease and Pharmacogenetics Research Group, University of Exeter, Exeter, UK.<br /><searchLink fieldCode="AU" term="%22Powell+N%22">Powell N</searchLink>; Department of Metabolism, Digestion and Reproduction, Imperial College London, London, UK.; Department of Gastroenterology, Imperial College Healthcare NHS Trust, London, UK.<br /><searchLink fieldCode="AU" term="%22Ahmad+T%22">Ahmad T</searchLink>; Department of Gastroenterology, Royal Devon and Exeter NHS Foundation Trust, Exeter, UK. tariq.ahmad1@nhs.net.; Exeter Inflammatory Bowel Disease and Pharmacogenetics Research Group, University of Exeter, Exeter, UK. tariq.ahmad1@nhs.net. – Name: AuthorCorporate Label: Corporate Authors Group: Au Data: <searchLink fieldCode="CA" term="%22CLARITY+IBD+study%22">CLARITY IBD study</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101528555%22">Nature communications</searchLink> [Nat Commun] 2022 Mar 16; Vol. 13 (1), pp. 1379. <i>Date of Electronic Publication: </i>2022 Mar 16. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Pub%2E+Group%22">Nature Pub. Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101528555 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2041-1723 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220411723%22">20411723 </searchLink><i>NLM ISO Abbreviation: </i>Nat Commun <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35296643 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/s41467-022-28517-z Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1379 Titles: – TitleFull: Antibody decay, T cell immunity and breakthrough infections following two SARS-CoV-2 vaccine doses in inflammatory bowel disease patients treated with infliximab and vedolizumab. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Lin S – PersonEntity: Name: NameFull: Kennedy NA – PersonEntity: Name: NameFull: Saifuddin A – PersonEntity: Name: NameFull: Sandoval DM – PersonEntity: Name: NameFull: Reynolds CJ – PersonEntity: Name: NameFull: Seoane RC – PersonEntity: Name: NameFull: Kottoor SH – PersonEntity: Name: NameFull: Pieper FP – PersonEntity: Name: NameFull: Lin KM – PersonEntity: Name: NameFull: Butler DK – PersonEntity: Name: NameFull: Chanchlani N – PersonEntity: Name: NameFull: Nice R – PersonEntity: Name: NameFull: Chee D – PersonEntity: Name: NameFull: Bewshea C – PersonEntity: Name: NameFull: Janjua M – PersonEntity: Name: NameFull: McDonald TJ – PersonEntity: Name: NameFull: Sebastian S – PersonEntity: Name: NameFull: Alexander JL – PersonEntity: Name: NameFull: Constable L – PersonEntity: Name: NameFull: Lee JC – PersonEntity: Name: NameFull: Murray CD – PersonEntity: Name: NameFull: Hart AL – PersonEntity: Name: NameFull: Irving PM – PersonEntity: Name: NameFull: Jones GR – PersonEntity: Name: NameFull: Kok KB – PersonEntity: Name: NameFull: Lamb CA – PersonEntity: Name: NameFull: Lees CW – PersonEntity: Name: NameFull: Altmann DM – PersonEntity: Name: NameFull: Boyton RJ – PersonEntity: Name: NameFull: Goodhand JR – PersonEntity: Name: NameFull: Powell N – PersonEntity: Name: NameFull: Ahmad T IsPartOfRelationships: – BibEntity: Dates: – D: 16 M: 03 Text: 2022 Mar 16 Type: published Y: 2022 Identifiers: – Type: issn-electronic Value: 2041-1723 Numbering: – Type: volume Value: 13 – Type: issue Value: 1 Titles: – TitleFull: Nature communications Type: main |
| ResultId | 1 |